2011

  1. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases

  2. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

  3. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

  4. Fructo-oligosaccharides in active Crohn’s disease

  5. Randomised clinical trial: the efficacy and safety of propionyl-l-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment